ANNOUNCED TODAY: Flatiron Health will be attending the 2024 International Society for Pharmacoepidemiology Annual Conference, showcasing how our evidence solutions can be leveraged to tackle vital questions in oncology pharmacoepidemiology. #ISPEAnnual2024 Our onsite events include: Are you ready for the future? How game-changing technology can unlock the next generation of RWE 🗓️Monday, August 26, 2024 at 12:30-1:30 PM CEST Blythe Adamson, PhD, MPH, Flatiron Health; Eric Meadows, Flatiron Health; Aaron Kamauu MD MS MPH, Navidence; Harriet Dickinson, Gilead Sciences Addressing RWE Transportability Concerns in Health Care Decision-Making. How to Do It Right? 🗓️Monday, August 26 | 3:30–5 PM CEST Blythe Adamson, PhD, MPH, Flatiron Health; Alind Gupta, University of Toronto; Evie Merinopoulou, Cytel; Alessandria Strübing, Daiichi Sankyo Europe GmbH; Stephen J. Duffield, NICE - National Institute for Health and Care Excellence Swipe through for a preview of our research ↘️ https://lnkd.in/eAN6Bs6S
Flatiron Health
Biotechnology Research
New York, New York 76,559 followers
Reimagining the infrastructure of cancer care
About us
Flatiron Health’s mission is to improve and extend lives by learning from the experience of every person with cancer.
- Website
-
http://www.flatiron.com
External link for Flatiron Health
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- New York, New York
- Type
- Privately Held
Locations
-
Primary
233 Spring St
5th Floor
New York, New York 10013, US
Employees at Flatiron Health
Updates
-
Watch our panel of experts representing views from across #clinicalresearch, drug commercialization and clinical practice and discuss the state of #breastcancer care today and where it is headed, including: - How organizations across the healthcare industry are tackling complex clinical decision-making - The use of #AI to accelerate breast cancer research and clinical practice - Treatment selection, sequencing and the increasingly critical role of genomic testing ⏯️ On demand now: https://lnkd.in/eAf2_-8z
-
What are the foundational steps Sponsors should take to design and execute more effective, efficient #clinicaltrials in the post-marketing space? 🔈 Hear from Flatiron Health’s Director of Clinical Operations, Josh Buddle on the potential we have within the space of post-marketing evidence generation, including the positive response we’ve received from running pragmatically-designed, #postmarketingstudies. Watch the full episode with Research Revolution: https://lnkd.in/edEGkzzM
-
With 230,000 new cases of lung cancer a year in the United States, it remains one of the most active areas of #cancerresearch today. Flatiron Health’s VP of Evidence Client Solutions, Christine Hung, shared her perspective on opportunities for lung cancer research and three industry case studies where #RWE supported critical research across the biopharma lifecycle. See what's possible with cross-industry collaborations and innovative solutions: http://spkl.io/60454hEwd
-
New research led by Flatiron Health in JNCI Cancer Spectrum shows patient groups historically underrepresented in oncology clinical trials are the very same patient groups more likely to be treated at community practices with limited or no access to trials. The research found, based on an analysis of over 550,000 patients across 178 community practices, that practices with low research engagement served higher proportions of patients who are Black, Latinx, without known insurance, and at the lowest socioeconomic status, while practices with high research engagement served higher proportions of patients who are White, insured, and at higher socioeconomic status. Deepening our understanding of which patient groups are facing inequitable access to trials is a key step in driving more representative oncology research. Visit our site for the full research and more on why this matters: http://spkl.io/60454hEux
-
"This study debunks some of the common myths about cancer clinical research in the community, specifically that community sites can only handle a few studies at a time or that they can't do phase 1." Hear more from author of #ASCO24 research, "Characterization of cancer clinical trials in the community setting," Ivy Altomare MD in a recent interview with Journal of Clinical Pathways for her perspective on how expanding #clinicaltrials in the community setting will facilitate optimal and equitable cancer care. http://spkl.io/60444Ctya
Characteristics of Clinical Trials in Community Oncology Practices Across the US
hmpgloballearningnetwork.com
-
A member of Flatiron's Trusted Partner Network, Canopy, is hosting an upcoming webinar to discuss recent changes and the reopening of the #EnhancingOncologyModel. For more information on how our Trusted Partner Network is driving value for community oncology, visit: https://lnkd.in/eY_63UiW
📢 Webinar Announcement! 📢 Considering joining the refined and reopened Enhancing Oncology Model (EOM)? Join Canopy for a webinar with thought leaders from the Centers for Medicare & Medicaid Services and community oncology as we delve into the EOM and strategies for value-based care. We'll cover: • New changes to the EOM and first thoughts from those considering joining • Strategies for success from current participants • How the EOM aligns with other quality programs like PCM/CCM and PIN Register now to secure your spot: https://lnkd.in/e54GXY8n
This content isn’t available here
Access this content and more in the LinkedIn app
-
TOMORROW: Join a panel of experts from clinical research, drug commercialization & clinical practice, for webinar ‘Bridging Innovation & Practice: The Current & Future Landscape of Breast Cancer Care' 📅 Tues, July 23 12-1 PM ET Register and submit your questions now: http://spkl.io/60444CyAQ
-
"By improving the speed and precision of data curation, and with our use of AI, we ensure that clinical trial designs are based on the most accurate and relevant information and can dynamically identify eligible patients for trials in real time." Craig Serra, Flatiron's Head of Clinical Research Scientific and Technical Engagement, sat down with The Clinical Trial Vanguard to discuss how we're revolutionizing oncology #clinicaltrials through innovative tech that integrates #RWD and #RWE ⬇️ https://lnkd.in/eZ78KKZX
How To Achieve Remarkable Results in Oncology Clinical Trials
https://www.clinicaltrialvanguard.com
-
What could #clinicalresearch teams do with more hours in their day? It’s been estimated that as much as 50% of data entry time in #clinicaltrials could be saved by using EHR to EDC connectors, which promise to remove duplicate data entry. Our latest research, published in the Journal of Clinical Oncology and presented at #ASCO24, sought to assess how EHR-to-EDC connectors like Flatiron Clinical Pipe™ can help reduce the burden of data entry and management in modern clinical trials. Hear from Ivy Altomare MD, Head of Research Oncology, and read our research in full on our website: http://spkl.io/60474CrRV